OTCMKTS:MKKGY Merck KGaA Earnings Date & Estimates $33.60 -0.18 (-0.52%) As of 02:51 PM Eastern Merck KGaA is estimated to report earnings on Thursday, November 12, 2026, before market opens. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement Announcement DateNovember 12, 2026TimeBefore Market Opens Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Merck KGaAMerck KGaA is expected to post earnings of $0.50 per share on revenue of $6.12 billion. In the same quarter a year earlier Merck KGaA reported $0.81 per share on revenue of $6.17 billion. Merck KGaA last reported on May 13, 2026, posting $0.59 per share and beating the $0.45 consensus estimate. Merck KGaA has beaten the consensus EPS estimate in 5 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.50Expected Revenue$6.12 billionPrior-Year EPS$0.81Prior-Year Revenue$6.17 billionExpected EPS Growth-38.3%Expected Revenue Growth-0.8%Recent Track RecordLast ReportedQ1 2026Last Quarter EPS$0.59 (Beat by +$0.14)Last Quarter Revenue$6.03 billionEPS Beat Rate5 of last 8 quartersPrepare for the Earnings CallEarnings HistoryCompany ProfileQ1 2026 Earnings ReportQ4 2025 Earnings ReportQ3 2025 Earnings Report Merck KGaA Earnings FAQ When does Merck KGaA report earnings? Merck KGaA (OTCMKTS:MKKGY) is estimated to report earnings on Thursday, November 12, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What is the consensus EPS estimate for Merck KGaA? Analysts expect Merck KGaA to post earnings of $0.50 per share for the quarter. How much revenue is Merck KGaA expected to report? The consensus revenue estimate for Merck KGaA is $6.12 billion for the quarter. Merck KGaA Earnings HeadlinesRBC Upbeat on Lonza's CDMO Deal with Merck KGaA; Forecasts UpdatedNovember 5, 2026 | marketscreener.comMMerck KGaA (MKKGY) Projected to Release Quarterly Earnings on ThursdayNovember 5, 2026 | americanbankingnews.comYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt death spiral. Interest payments alone now top a trillion dollars a year. The Social Security trust fund is projected to run dry by 2032, which could trigger an automatic 22% cut to benefits. Between 2020 and 2022, the Fed expanded the money supply by 41%. A free 27 page report breaks down these numbers in plain English, including what central banks have been doing with gold.November 10 at 1:00 AM | American Alternative (Ad)Merck KGaA : UBS reiterates its Neutral ratingNovember 4, 2026 | marketscreener.comMLonza Signs Agreement to Acquire US CDMO Network from Merck KGaA, Darmstadt, Germany, and Significantly Expands its US PresenceNovember 3, 2026 | markets.ft.comLonza Group To Buy Merck's CDMO BusinessNovember 3, 2026 | rttnews.comSee More Merck KGaA Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Merck KGaA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merck KGaA and other key companies, straight to your email. Email Address About Merck KGaAMerck KGaA (OTCMKTS:MKKGY) is a German science and technology company headquartered in Darmstadt. Founded in 1668, it traces its origins to a pharmacy established by the Merck family and has grown into a global business serving customers in healthcare, research and industry. It is separate from the U.S.-based Merck & Co. The company operates through three main businesses. Its Healthcare division develops and markets prescription medicines, including treatments in areas such as oncology, neurology and fertility. Life Science supplies laboratory products, research tools and services, as well as materials and technologies used in pharmaceutical manufacturing. Through its Electronics division, Merck provides specialty materials and solutions for the semiconductor and display industries. The company serves customers internationally, with operations and markets spanning numerous regions around the world.View Merck KGaA ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles D-Wave Quantum Has Long-Term Potential, But Is Now the Time to Buy?Archer Aviation's FAA Certificate Is a Milestone, But It Isn't the Final OneDraftKings Just Lost 20%—And Its Biggest Gamble Is Still AheadBarrick's Earnings Beat Could Be Overshadowed by an Even Bigger OpportunityAxon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?Microsoft’s Neocloud Pullback Isn’t a Crack in AI DemandOklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next? Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
